{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:55:21Z","timestamp":1794970521094,"version":"4.9.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:00:00Z","timestamp":1751673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan University Talent Program","award":["SYLYC2022095"],"award-info":[{"award-number":["SYLYC2022095"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32161143021"],"award-info":[{"award-number":["32161143021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["182300410313"],"award-info":[{"award-number":["182300410313"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02331-3","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T22:19:35Z","timestamp":1751667575000},"page":"4364-4378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["ACE2 Alleviates Microglia Neuroinflammation by RANK-RANKL-OPG Axis in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"48","author":[{"given":"Yuxiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowu","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,5]]},"reference":[{"issue":"7","key":"2331_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira, A. H. V., K. R. Chaudhuri, and P. Jenner. 2017. Non-motor features of Parkinson disease. Nature Reviews Neuroscience 18(7):435\u2013450.","journal-title":"Nature Reviews Neuroscience"},{"issue":"4","key":"2331_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00018-014-1774-1","volume":"72","author":"JN Le Grand","year":"2015","unstructured":"Le Grand, J. N., L. Gonzalez-Cano, M. A. Pavlou, and J. C. Schwamborn. 2015. Neural stem cells in parkinson\u2019s disease: A role for neurogenesis defects in onset and progression. Cellular and Molecular Life Sciences 72(4):773\u2013797.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"2331_CR3","doi-asserted-by":"crossref","unstructured":"Zhu, B., D. Yin, H. Zhao, and L. Zhang. 2022. The immunology of Parkinson\u2019s disease.\u00a0Seminars in Immunopathology.","DOI":"10.1007\/s00281-022-00947-3"},{"issue":"1","key":"2331_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li, X., C. Li, W. Zhang, Y. Wang, P. Qian, and H. Huang. 2023. Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct Target Ther 8(1):239.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2331_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12974-023-02723-y","volume":"20","author":"Y Xu","year":"2023","unstructured":"Xu, Y., Y. Li, C. Wang, T. Han, H. Liu, L. Sun, J. Hong, M. Hashimoto, and J. Wei. 2023. The reciprocal interactions between microglia and T cells in parkinson\u2019s disease: A double-edged sword. J Neuroinflammation 20(1):33.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"2331_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.4103\/1673-5374.385845","volume":"19","author":"T Han","year":"2024","unstructured":"Han, T., Y. Xu, L. Sun, M. Hashimoto, and J. Wei. 2024. Microglial response to aging and neuroinflammation in the development of neurodegenerative diseases. Neural Regen Res 19(6):1241\u20131248.","journal-title":"Neural Regen Res"},{"key":"2331_CR7","doi-asserted-by":"publisher","first-page":"147609","DOI":"10.1016\/j.brainres.2021.147609","volume":"1769","author":"SD Nielsen","year":"2021","unstructured":"Nielsen, S. D., N. M. Pearson, and K. Seidler. 2021. The link between the gut microbiota and parkinson\u2019s disease: A systematic mechanism review with focus on \u03b1-synuclein transport. Brain Research 1769:147609.","journal-title":"Brain Research"},{"key":"2331_CR8","doi-asserted-by":"publisher","first-page":"102171","DOI":"10.1016\/j.arr.2023.102171","volume":"94","author":"A Elangovan","year":"2024","unstructured":"Elangovan, A., B. Dahiya, L. Kirola, M. Iyer, P. Jeeth, S. Maharaj, N. Kumari, V. Lakhanpal, T. M. Michel, and K. Rao et al. 2024. Does gut brain axis has an impact on parkinson\u2019s disease (PD)? Ageing Research Reviews 94:102171.","journal-title":"Ageing Research Reviews"},{"issue":"1","key":"2331_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12974-024-03041-7","volume":"21","author":"JB Kim","year":"2024","unstructured":"Kim, J. B., Y. Kim, S. J. Kim, T. Y. Ha, D. K. Kim, D. W. Kim, M. So, S. H. Kim, H. G. Woo, D. Yoon, and S. M. Park. 2024. Integration of National health insurance claims data and animal models reveals Fexofenadine as a promising repurposed drug for parkinson\u2019s disease. J Neuroinflammation 21(1):53.","journal-title":"J Neuroinflammation"},{"issue":"23","key":"2331_CR10","first-page":"e2448","volume":"94","author":"A Camacho-Soto","year":"2020","unstructured":"Camacho-Soto, A., A. Gross, S. Searles Nielsen, A. N. Miller, M. N. Warden, A. Salter, and B. A. Racette. 2020. Fractures in the Prodromal Period of Parkinson Disease Neurology 94(23):e2448\u2013e2456.","journal-title":"Fractures in the Prodromal Period of Parkinson Disease Neurology"},{"key":"2331_CR11","doi-asserted-by":"publisher","first-page":"634213","DOI":"10.3389\/fnagi.2021.634213","volume":"13","author":"Y Lin","year":"2021","unstructured":"Lin, Y., M. Zhou, W. Dai, W. Guo, J. Qiu, Z. Zhang, M. Mo, L. Ding, P. Ye, and Y. Wu et al. 2021. Bone-Derived factors as potential biomarkers for parkinson\u2019s disease. Frontiers in Aging Neuroscience 13:634213.","journal-title":"Frontiers in Aging Neuroscience"},{"key":"2331_CR12","doi-asserted-by":"crossref","unstructured":"Hepp, D. H., T. A. van Wageningen, K. L. Kuiper, K. D. van Dijk, L. P. Oosterveld, H. W. Berendse, and W. D. J. van de Berg. 2023. Inflammatory blood biomarkers are associated with long-term clinical disease severity in Parkinson\u2019s disease.\u00a0International Journal of Molecular Sciences,\u00a024(19):14915.","DOI":"10.3390\/ijms241914915"},{"issue":"5","key":"2331_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41584-022-00764-w","volume":"18","author":"B So\u00f3s","year":"2022","unstructured":"So\u00f3s, B., \u00c1 Szentp\u00e9tery, H. G. Raterman, W. F. Lems, H. P. Bhattoa, and Z. Szekanecz. 2022. Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases. Nature Reviews Rheumatology 18(5):249\u2013257.","journal-title":"Nature Reviews Rheumatology"},{"issue":"1","key":"2331_CR14","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1038\/s41467-022-32435-5","volume":"13","author":"J Xiong","year":"2022","unstructured":"Xiong, J., J. Liao, X. Liu, Z. Zhang, J. Adams, R. Pacifici, and K. Ye. 2022. A TrkB agonist prodrug prevents bone loss via inhibiting asparagine endopeptidase and increasing osteoprotegerin. Nature Communications 13(1):4820.","journal-title":"Nature Communications"},{"key":"2331_CR15","doi-asserted-by":"publisher","first-page":"590480","DOI":"10.3389\/fneur.2020.590480","volume":"11","author":"A Glasnovi\u0107","year":"2020","unstructured":"Glasnovi\u0107, A., N. O\u2019Mara, N. Kova\u010di\u0107, D. Gr\u010devi\u0107, and S. Gajovi\u0107. 2020. RANK\/RANKL\/OPG signaling in the brain: a systematic review of the literature. Frontiers in Neurology 11:590480.","journal-title":"Frontiers in Neurology"},{"issue":"22","key":"2331_CR16","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.1073\/pnas.1400544111","volume":"111","author":"M Shimamura","year":"2014","unstructured":"Shimamura, M., H. Nakagami, M. K. Osako, H. Kurinami, H. Koriyama, P. Zhengda, H. Tomioka, A. Tenma, K. Wakayama, and R. Morishita. 2014. OPG\/RANKL\/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. Proc Natl Acad Sci U S A 111(22):8191\u20138196.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2331_CR17","doi-asserted-by":"crossref","unstructured":"Freeman C, A SM, A SP. 2024. Unraveling the intricacies of OPG\/RANKL\/RANK biology and its implications in neurological disorders-a comprehensive literature review.\u00a0Molecular Neurobiology\u00a061(12):10656\u201310670.","DOI":"10.1007\/s12035-024-04227-z"},{"issue":"1","key":"2331_CR18","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1186\/s12879-024-09941-6","volume":"24","author":"S Kazemi-Sufi","year":"2024","unstructured":"Kazemi-Sufi, S., S. Alipour, M. Rabieepour, S. Roshan-Milani, and R. Naderi. 2024. Serum Proinflammatory cytokines, receptor activator of nuclear factor kappa-\u0392 ligand (RANKL), osteoprotegerin (OPG) and RANKL\/OPG ratio in mild and severe COVID-19. Bmc Infectious Diseases 24(1):1047.","journal-title":"Bmc Infectious Diseases"},{"issue":"1","key":"2331_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/hr.2012.161","volume":"36","author":"AC Arnold","year":"2013","unstructured":"Arnold, A.C., P.E. Gallagher, and D.I. Diz. 2013. Brain renin-angiotensin system in the nexus of hypertension and aging. Hypertension Research 36 (1): 5\u201313.","journal-title":"Hypertension Research"},{"key":"2331_CR20","doi-asserted-by":"crossref","unstructured":"Angelopoulou, E., E. Karlafti, V. E. Georgakopoulou, P. Papalexis, S. G. Papageorgiou, T. Tegos, and C. Savopoulos. 2023. Exploring the role of ACE2 as a connecting link between COVID-19 and Parkinson\u2019s disease. Life (Basel), 13(2):536.","DOI":"10.3390\/life13020536"},{"issue":"6","key":"2331_CR21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11064-018-2679-4","volume":"44","author":"N Alenina","year":"2019","unstructured":"Alenina, N., and M. Bader. 2019. ACE2 in brain physiology and pathophysiology: Evidence from Transgenic animal models. Neurochemical Research 44 (6): 1323\u20131329.","journal-title":"Neurochemical Research"},{"issue":"2","key":"2331_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3758\/s13415-024-01171-2","volume":"24","author":"S Gencturk","year":"2024","unstructured":"Gencturk, S., and G. Unal. 2024. Rodent tests of depression and anxiety: Construct validity and translational relevance. Cognitive, Affective & Behavioral Neuroscience 24(2):191\u2013224.","journal-title":"Cognitive, Affective & Behavioral Neuroscience"},{"issue":"2","key":"2331_CR23","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf, A.A., and C.A. Frye. 2007. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nature Protocols 2 (2): 322\u2013328.","journal-title":"Nature Protocols"},{"issue":"1","key":"2331_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-021-00272-w","volume":"8","author":"M Yan","year":"2022","unstructured":"Yan, M., M. Xiong, L. Dai, X. Zhang, Y. Zha, X. Deng, Z. Yu, and Z. Zhang. 2022. Cofilin 1 promotes the pathogenicity and transmission of pathological \u03b1-synuclein in mouse models of parkinson\u2019s disease. NPJ Parkinsons Dis 8(1):1.","journal-title":"NPJ Parkinsons Dis"},{"issue":"8","key":"2331_CR25","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/NEN.0b013e318180f0bd","volume":"67","author":"AL McCormack","year":"2008","unstructured":"McCormack, A. L., S. K. Mak, M. Shenasa, W. J. Langston, L. S. Forno, and D. A. Di Monte. 2008. Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys. Journal of Neuropathology and Experimental Neurology 67(8):793\u2013802.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"9","key":"2331_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.31083\/j.jin2309175","volume":"23","author":"L Rani","year":"2024","unstructured":"Rani, L., and A. C. Mondal. 2024. Vanillin mitigates the MPTP-Induced \u03b1-Synucleinopathy in a mouse model of parkinson\u2019s disease: Insights into the involvement of Wnt\/\u03b2-Catenin signaling. Journal of Integrative Neuroscience 23(9):175.","journal-title":"Journal of Integrative Neuroscience"},{"issue":"10","key":"2331_CR27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/aps.2017.49","volume":"38","author":"QS Zhang","year":"2017","unstructured":"Zhang, Q. S., Y. Heng, Z. Mou, J. Y. Huang, Y. H. Yuan, and N. H. Chen. 2017. Reassessment of subacute MPTP-treated mice as animal model of parkinson\u2019s disease. Acta Pharmacologica Sinica 38(10):1317\u20131328.","journal-title":"Acta Pharmacologica Sinica"},{"key":"2331_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuro.2021.02.001","volume":"84","author":"MM Merghani","year":"2021","unstructured":"Merghani, M.M., M.T. Ardah, M. Al Shamsi, T. Kitada, and M.E. Haque. 2021. Dose-related biphasic effect of the Parkinson\u2019s disease neurotoxin MPTP, on the spread, accumulation, and toxicity of \u03b1-synuclein. Neurotoxicology 84: 41\u201352.","journal-title":"Neurotoxicology"},{"issue":"2","key":"2331_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1471-4159.2001.00174.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski, S., Q. Chen, M. Vila, B. I. Giasson, R. Djaldatti, S. Vukosavic, J. M. Souza, V. Jackson-Lewis, V. M. Lee, and H. Ischiropoulos. 2001. Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of parkinson\u2019s disease. Journal of Neurochemistry 76(2):637\u2013640.","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"2331_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","volume":"74","author":"M Vila","year":"2000","unstructured":"Vila, M., S. Vukosavic, V. Jackson-Lewis, M. Neystat, M. Jakowec, and S. Przedborski. 2000. Alpha-synuclein up-regulation in substantia Nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. Journal of Neurochemistry 74(2):721\u2013729.","journal-title":"Journal of Neurochemistry"},{"key":"2331_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neulet.2017.02.076","volume":"645","author":"L Lisi","year":"2017","unstructured":"Lisi, L., G. M. Ciotti, D. Braun, S. Kalinin, D. Curr\u00f2, C. Dello Russo, A. Coli, A. Mangiola, C. Anile, D. L. Feinstein, and P. Navarra. 2017. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma. Neuroscience Letters 645:106\u2013112.","journal-title":"Neuroscience Letters"},{"issue":"1","key":"2331_CR32","doi-asserted-by":"publisher","first-page":"36e31","DOI":"10.1016\/j.urolonc.2013.02.012","volume":"32","author":"D Gerhardt","year":"2014","unstructured":"Gerhardt, D., G. Bertola, F. Dietrich, F. Figueir\u00f3, A. Zanotto-Filho, J. C. Moreira Fonseca, F. B. Morrone, C. H. Barrios, A. M. Battastini, and C. G. Salbego. 2014. Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3\u03b2. Urologic Oncology 32(1):36e31\u201336e39.","journal-title":"Urologic Oncology"},{"key":"2331_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.intimp.2017.08.013","volume":"51","author":"H Zhao","year":"2017","unstructured":"Zhao, H., H. Xu, S. Qiao, C. Lu, G. Wang, M. Liu, B. Guo, Y. Tan, D. Ju, and C. Xiao. 2017. Boldine isolated from Litsea cubeba inhibits bone resorption by suppressing the osteoclast differentiation in collagen-induced arthritis. International Immunopharmacology 51:114\u2013123.","journal-title":"International Immunopharmacology"},{"key":"2331_CR34","doi-asserted-by":"crossref","unstructured":"Ravenhill, S. M., A. H. Evans, and S. G. Crewther. 2023. Escalating bi-directional feedback loops between proinflammatory microglia and mitochondria in ageing and post-diagnosis of Parkinson\u2019s disease. Antioxidants (Basel)\u00a012(5):1117.","DOI":"10.3390\/antiox12051117"},{"issue":"8","key":"2331_CR35","doi-asserted-by":"publisher","first-page":"e2209177120","DOI":"10.1073\/pnas.2209177120","volume":"120","author":"LH Fairley","year":"2023","unstructured":"Fairley, L. H., K. O. Lai, J. H. Wong, W. J. Chong, A. S. Vincent, G. D\u2019Agostino, X. Wu, R. R. Naik, A. Jayaraman, and S. R. Langley et al. 2023. Mitochondrial control of microglial phagocytosis by the translocator protein and hexokinase 2 in alzheimer\u2019s disease. Proc Natl Acad Sci U S A 120(8):e2209177120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2331_CR36","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s43587-023-00479-x","volume":"3","author":"X Li","year":"2023","unstructured":"Li, X., Y. Li, Y. Jin, Y. Zhang, J. Wu, Z. Xu, Y. Huang, L. Cai, S. Gao, and T. Liu et al. 2023. Transcriptional and epigenetic decoding of the microglial aging process. Nat Aging 3(10):1288\u20131311.","journal-title":"Nat Aging"},{"issue":"9","key":"2331_CR37","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00011-022-01616-9","volume":"71","author":"L Sapra","year":"2022","unstructured":"Sapra, L., C. Saini, B. Garg, R. Gupta, B. Verma, P. K. Mishra, and R. K. Srivastava. 2022. Long-term implications of COVID-19 on bone health: Pathophysiology and therapeutics. Inflammation Research 71(9):1025\u20131040.","journal-title":"Inflammation Research"},{"issue":"9","key":"2331_CR38","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/jor.25537","volume":"41","author":"AK Haudenschild","year":"2023","unstructured":"Haudenschild, A. K., B. A. Christiansen, S. Orr, E. E. Ball, C. M. Weiss, H. Liu, D. P. Fyhrie, J. H. N. Yik, L. L. Coffey, and D. R. Haudenschild. 2023. Acute bone loss following SARS-CoV-2 infection in mice. Journal of Orthopaedic Research 41(9):1945\u20131952.","journal-title":"Journal of Orthopaedic Research"},{"key":"2331_CR39","doi-asserted-by":"publisher","first-page":"115041","DOI":"10.1016\/j.bone.2019.115041","volume":"128","author":"CM Queiroz-Junior","year":"2019","unstructured":"Queiroz-Junior, C.M., A. Santos, I. Galv\u00e3o, G.R. Souto, R.A. Mesquita, M.A. S\u00e1, and A.J. Ferreira. 2019. The angiotensin converting enzyme 2\/angiotensin-(1\u20137)\/Mas Receptor axis as a key player in alveolar bone remodeling. Bone 128:115041.","journal-title":"Bone"},{"issue":"1","key":"2331_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11914-023-00843-1","volume":"22","author":"A Harris","year":"2024","unstructured":"Harris, A., A. Creecy, O. D. Awosanya, T. McCune, M. V. Ozanne, A. J. Toepp, M. A. Kacena, and X. Qiao. 2024. SARS-CoV-2 and its multifaceted impact on bone health: Mechanisms and clinical evidence. Current Osteoporosis Reports 22(1):135\u2013145.","journal-title":"Current Osteoporosis Reports"},{"issue":"1","key":"2331_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11914-023-00842-2","volume":"22","author":"A Creecy","year":"2024","unstructured":"Creecy, A., O. D. Awosanya, A. Harris, X. Qiao, M. Ozanne, A. J. Toepp, M. A. Kacena, and T. McCune. 2024. COVID-19 and bone loss: A review of risk factors, mechanisms, and future directions. Current Osteoporosis Reports 22(1):122\u2013134.","journal-title":"Current Osteoporosis Reports"},{"issue":"2","key":"2331_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/glia.24465","volume":"72","author":"J Ni","year":"2023","unstructured":"Ni, J., Z. Xie, Z. Quan, J. Meng, and H. Qing. 2023. How brain \u2018cleaners\u2019 fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer\u2019s disease. Glia 72 (2): 227\u2013244.","journal-title":"Glia"},{"issue":"7","key":"2331_CR43","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1080\/15548627.2023.2165313","volume":"19","author":"S Beccari","year":"2023","unstructured":"Beccari, S., V. Sierra-Torre, J. Valero, M. Pereira-Iglesias, M. Garc\u00eda-Zaballa, F.N. Soria, L. De Las Heras-Garcia, A. Carretero-Guillen, E. Capetillo-Zarate, M. Domercq, et al. 2023. Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy. Autophagy 19 (7): 1952\u20131981.","journal-title":"Autophagy"},{"key":"2331_CR44","doi-asserted-by":"publisher","first-page":"102232","DOI":"10.1016\/j.arr.2024.102232","volume":"95","author":"L Kou","year":"2024","unstructured":"Kou, L., X. Chi, Y. Sun, S. Yin, J. Wu, W. Zou, Y. Wang, Z. Jin, J. Huang, and N. Xiong et al. 2024. Circadian regulation of microglia function: Potential targets for treatment of parkinson\u2019s disease. Ageing Research Reviews 95:102232.","journal-title":"Ageing Research Reviews"},{"issue":"1","key":"2331_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao, C., J. Jiang, Y. Tan, and S. Chen. 2023. Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359.","journal-title":"Signal Transduct Target Ther"},{"key":"2331_CR46","doi-asserted-by":"crossref","unstructured":"Zhang, C., X. Cao, H. Wang, Z. Li, and Y. Zhang. 2023. The ACE2 activator diminazene aceturate ameliorates colitis by repairing the gut-vascular barrier in mice.\u00a0Microvascular Research\u00a0148:104544.","DOI":"10.1016\/j.mvr.2023.104544"},{"issue":"7","key":"2331_CR47","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/CS20130344","volume":"126","author":"B Patel Vaibhav","year":"2013","unstructured":"Patel Vaibhav, B., N. Parajuli, and Y. Oudit Gavin. 2013. Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications. Clinical Science 126(7):471\u2013482.","journal-title":"Clinical Science"},{"issue":"6","key":"2331_CR48","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1021\/acscentsci.3c00377","volume":"9","author":"T Zhao","year":"2023","unstructured":"Zhao, T., F. He, K. Zhao, L. Yuxia, H. Li, X. Liu, J. Cen, and S. Duan. 2023. A Triple-Targeted Rutin-Based Self-Assembled delivery vector for treating ischemic stroke by vascular normalization and Anti-Inflammation via ACE2\/Ang1-7 signaling. ACS Central Science 9(6):1180\u20131199.","journal-title":"ACS Central Science"},{"key":"2331_CR49","doi-asserted-by":"crossref","unstructured":"Cui, C., P. Xu, G. Li, Y. Qiao, W. Han, C. Geng, D. Liao, M. Yang, D. Chen, and P. Jiang. 2019. Vitamin D receptor activation regulates microglia polarization and oxidative stress in spontaneously hypertensive rats and angiotensin II-exposed microglial cells: role of renin-angiotensin system.\u00a0Redox Biology\u00a026:101295.","DOI":"10.1016\/j.redox.2019.101295"},{"issue":"4","key":"2331_CR50","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2174\/1871528113666140713164506","volume":"13","author":"RR Gaddam","year":"2014","unstructured":"Gaddam, R. R., S. Chambers, and M. Bhatia. 2014. ACE and ACE2 in inflammation: A Tale of two enzymes. Inflammation & Allergy: Drug Targets 13(4):224\u2013234.","journal-title":"Inflammation & Allergy: Drug Targets"},{"key":"2331_CR51","doi-asserted-by":"crossref","unstructured":"Mkhize, B. C., P. Mosili, P. S. Ngubane, N. H. Sibiya, and A. Khathi. 2023. The relationship between Renin-Angiotensin-Aldosterone system (RAAS) activity, osteoporosis and estrogen deficiency in type 2 diabetes.\u00a0International Journal of Molecular Sciences\u00a024(15):11963.","DOI":"10.3390\/ijms241511963"},{"issue":"1\u20132","key":"2331_CR52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.mce.2012.05.002","volume":"361","author":"M Tsubaki","year":"2012","unstructured":"Tsubaki, M., T. Satou, T. Itoh, M. Imano, M. Yanae, C. Kato, R. Takagoshi, M. Komai, and S. Nishida. 2012. Bisphosphonate- and statin-induced enhancement of OPG expression and Inhibition of CD9, M-CSF, and RANKL expressions via Inhibition of the ras\/mek\/erk pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. Molecular and Cellular Endocrinology 361(1\u20132):219\u2013231.","journal-title":"Molecular and Cellular Endocrinology"},{"key":"2331_CR53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","volume":"40","author":"T Ono","year":"2020","unstructured":"Ono, T., M. Hayashi, F. Sasaki, and T. Nakashima. 2020. RANKL biology: Bone metabolism, the immune system, and beyond. Inflammation and Regeneration 40:2.","journal-title":"Inflammation and Regeneration"},{"issue":"2","key":"2331_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41419-019-1380-0","volume":"10","author":"RQ Chang","year":"2019","unstructured":"Chang, R. Q., J. Shao, Y. H. Meng, J. Wang, D. J. Li, and M. Q. Li. 2019. Decidual RANKL\/RANK interaction promotes the residence and polarization of TGF-\u03b21-producing regulatory \u03b3\u03b4 T cells. Cell Death and Disease 10(2):113.","journal-title":"Cell Death and Disease"},{"key":"2331_CR55","doi-asserted-by":"publisher","first-page":"107682","DOI":"10.1016\/j.pharmthera.2020.107682","volume":"218","author":"M Honma","year":"2021","unstructured":"Honma, M., Y. Ikebuchi, and H. Suzuki. 2021. RANKL as a key figure in bridging between the bone and immune system: Its physiological functions and potential as a Pharmacological target. Pharmacology & Therapeutics 218:107682.","journal-title":"Pharmacology & Therapeutics"},{"key":"2331_CR56","doi-asserted-by":"publisher","first-page":"106872","DOI":"10.1016\/j.intimp.2020.106872","volume":"88","author":"HY Kim","year":"2020","unstructured":"Kim, H. Y., H. G. Kang, S. Y. Nam, H. M. Kim, and H. J. Jeong. 2020. Blockade of RANKL\/RANK signaling pathway by Epigallocatechin gallate alleviates mast cell-mediated inflammatory reactions. International Immunopharmacology 88:106872.","journal-title":"International Immunopharmacology"},{"issue":"44","key":"2331_CR57","doi-asserted-by":"publisher","first-page":"eadf5238","DOI":"10.1126\/sciadv.adf5238","volume":"9","author":"NG Kondegowda","year":"2023","unstructured":"Kondegowda, N. G., J. Filipowska, J. S. Do, N. Leon-Rivera, R. Li, R. Hampton, S. Ogyaadu, C. Levister, J. M. Penninger, and H. Reijonen et al. 2023. RANKL\/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes. Science Advances 9(44):eadf5238.","journal-title":"Science Advances"},{"issue":"6","key":"2331_CR58","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.immuni.2015.10.017","volume":"43","author":"MM Guerrini","year":"2015","unstructured":"Guerrini, M.M., K. Okamoto, N. Komatsu, S. Sawa, L. Danks, J.M. Penninger, T. Nakashima, and H. Takayanagi. 2015. Inhibition of the TNF family cytokine RANKL prevents autoimmune inflammation in the central nervous system. Immunity 43 (6): 1174\u20131185.","journal-title":"Immunity"},{"key":"2331_CR59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejphar.2017.04.031","volume":"807","author":"HM Abuohashish","year":"2017","unstructured":"Abuohashish, H. M., M. M. Ahmed, D. Sabry, M. M. Khattab, and S. S. Al-Rejaie. 2017. The ACE-2\/Ang1-7\/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor Blockade. European Journal of Pharmacology 807:44\u201355.","journal-title":"European Journal of Pharmacology"},{"issue":"17","key":"2331_CR60","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1042\/CS20240771","volume":"138","author":"MF Hammer","year":"2024","unstructured":"Hammer, M. F., E. Bahramnejad, J. C. Watkins, and P. T. Ronaldson. 2024. Candesartan restores blood-brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis. Clin Sci (Lond) 138(17):1089\u20131110.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"2331_CR61","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13287-024-03751-y","volume":"15","author":"AI Rodr\u00edguez-P\u00e9rez","year":"2024","unstructured":"Rodr\u00edguez-P\u00e9rez, A. I., P. Garrido-Gil, M. Garc\u00eda-Garrote, A. Mu\u00f1oz, J. A. Parga, J. L. Labandeira-Garc\u00eda, and J. Rodr\u00edguez-Pallares. 2024. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in parkinson\u2019s disease models. Stem Cell Research & Therapy 15(1):138.","journal-title":"Stem Cell Research & Therapy"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02331-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02331-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02331-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:02:51Z","timestamp":1766412171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02331-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":61,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2331"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02331-3","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,5]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiments using mice were approved by the Institutional Animal Care and Use Committee of Henan University, China and were performed in accordance with the committee\u2019s guiding principle (approval No. HUSOM2021-161).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}